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Abstract
To date, even widely studied, there is not a standard diagnostic method to detect 
neurocysticercotic patients. The later due to the complex nature of cysticercosis 
disease and the simplicity of common immunological assumptions involved in 
explaining the low scores and reproducibility of immunotests in the diagnosis 
of neurocysticercosis. To begin with, the few studies dealing with the immune 
response during neurocysticercosis are not conclusive, which of course it is crucial 
to develop an immunodiagnostic test. Their full recognition should clear confusion 
and reduce controversy as well as provide avenues of research and technological 
design. In here, logical arguments add that even under common immunological 
assumptions, serology of neurocysticercosis will always include false negative 
and positive results. Thus, serology is no strong support for medical diagnosis of 
neurocysticercosis (NC). In contrast, immunotests performed in the cerebrospinal 
fluid (CSF) of neurological patients should have fewer false positive and fewer false 
negatives than in serum. To conclude, it is argued that high scores in serology for 
NC will not yield to usual approaches and that success needs of a concerted world-
wide effort. A more punctilious strategy based on the design of panels of confirmed 
positive and negative sera needs to be construed, shared and tested by all interested 
groups to obtain comparable results. The identification of a set of specific and rep-
resentative antigens of Taenia solium (T. solium) and a thorough compilation of the 
many forms of antibody response of humans to the many forms of T. solium disease 
are also to be considered as one of the most importants factors to the disease.
Keywords: Cysticercosis, Neglected Diseases, Neurocysticercosis, Immunodiagnosis
1. Introduction
Neurocysticercosis (NC) is a disease caused by the larvae (or cysticerci) of the 
intestinal parasite Taenia solium (T. solium) when the cysticerci lodges in the central 
nervous system (CNS). It is considered one of the most important parasitic disease of 
the CNS [1–3]. Cysticerci may infect humans and may also locate elsewhere of CNS, in 
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skeletal muscles, heart, eyes, diaphragm, tongue and subcutaneous tissues, causing a 
condition simply referred to as cysticercosis. Cysticerci develop in humans and also in 
pigs from eggs produced by the adult tapeworm living in the intestine of humans and 
shed to the environment upon defecation, thus contaminating soil, waters and food.
The most serious condition of T. solium disease affecting human health is NC. An 
estimated 60% of NC cases are non-symptomatic [4], while the rest are symptom-
atic and exhibit a wide variety of neurological symptoms, being chronic epilepsy 
and headache the most noticeable [4–6]. Severe forms of NC develop meningitis, 
encephalitis, arteritis, areas of cerebral infarction and gliosis, as well as anatomical 
distortion and compression of intracranial structures causing blockade in the flow 
of cerebrospinal-fluid (CSF) [5–7], frequently leading to endo-cranial hypertension 
and requiring specialized medical attention and/or surgery to derive CSF and/or 
remove the parasite. The severe forms of NC seriously impair the patients´ health 
and may lead to death. Medical diagnosis of NC is impossible on clinical data alone 
as it presents a variety of nonspecific symptoms [8], while confirmatory diagnosis 
is established by biopsy, cranial CAT-scans and/or cranial NMR images showing 
nodular lesions of the brain usually suffice in most cases.
Immunodiagnosis of NC (IDxNC) has long been sought because of the dis-
ease’s prolonged silent or ambiguous clinical pictures and also because of the low 
accessibility and impossibly high costs of CAT-scans and NMR-images in endemic 
countries [1, 9–11]. Not only an effective IDxNC would be a most practical way 
to facilitate medical diagnosis for millions of poor people in endemic countries, 
it would also supply sero-epidemiological studies with a low-cost indicator of 
prevalence of infection. In addition, a positive immune-test would rise the clinical 
suspicion of early non-symptomatic NC which, if confirmed, would allow to offer 
early treatment before the parasite does much irreversible CNS damage. Further, 
simplification of copro-parasitological studies in stools by an immune-test would 
help to identify carriers of live tapeworms and treat them in order to interrupt 
transmission in the explosive stage of massive egg production.
Many immunological methods have been tried to detect antibodies and/or 
antigens of T. solium in serum or CSF and feces, and even in urine and saliva [12–16], 
with variable levels of success in detecting NC cases and tapeworm carriers [17, 18].  
The gallery includes in vitro tests using complement fixation, precipitation, agglu-
tination, radioimmunoassay and enzyme-based detection systems (ELISA and 
Western Blots) [8, 19, 20]. Antigens used in diagnosis also vary from whole antigen 
extracts [14, 21, 22], secreted antigens [23–27], semi-purified fractions and purified 
natural proteins [6, 12, 16, 28] to recombinant proteins [4, 6, 8–11, 29, 30], and syn-
thetic peptides [31–33], either from T. solium or from homologous parasites as Taenia 
crassiceps [2, 13, 19, 21, 32, 34], Taenia saginata [22, 35] or Taenia taeniaeformis [36]. 
Most reports initially claim very high specificity/sensitivity scores, sometimes even 
as high as 100/100%. Enthusiasm soon calms as the methods are applied by different 
laboratories, in larger numbers of cases and in various epidemiological scenarios 
of the disease [14, 28, 37, 38]. A sober statement about the state of the art at present 
times would claim a sensitivity that ranges from 50 to 85% (15–50% false positives) 
and a specificity of about 80–90% (10--20% false negatives), with large variations 
within and between tests and low reproducibility between laboratories [14, 28, 38].
2. Generalities of immune response to Taenia solium cysticercosis
In recent times it has been found that cysticercosis is importantly driven by 
the hosts neuroendocrine system function, particularly sex steroid hormones 
(Morales-Montor and Larralde c, 2005). Taenia parasites have developed elaborate 
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mechanisms of interacting with their intermediate hosts. The oncospheres which 
invade the intermediate host are susceptible to antibody and complement. However, 
by the time the host has generated an antibody response, the parasites have begun 
to transform to the more resistant metacestode. The metacestodes have elaborate 
means of evading complement-mediated destruction, including paramyosin which 
inhibits C1q, taeniaestatin which inhibits both classical and alternate pathways, 
and sulfated polysaccharides which activate complement away from the parasite. 
Similarly, antibody does not seem to be able to kill the mature metacestode. In 
fact, the parasites may even stimulate the host to produce antibody, which could 
be bound via Fc receptors and used as a source of protein. Finally, taeniaestatin 
and other poorly defined factors may interfere with lymphocyte proliferation and 
macrophage function, thus paralyzing the cellular immune response. Since the 
symptoms of NC are typically associated with a brisk inflammatory response, we 
hypothesize that disease is primarily caused by injured or dying parasites. This 
hypothesis raises important questions in assessing the role of chemotherapy in the 
management of NC, as well as in the evaluation of clinical trials, most of which 
were uncontrolled (Morales-Montor et al., 2006).
The generation of protective T cell responses to cysticercosis is a complex pro-
cess in which cytokines and costimulatory molecules provide signals that direct the 
development of adaptative immunity (13). The characterization of T cell responses 
as belonging to either Th1-type responses (dominated by the production of IFN-γ 
and associated with cell-mediated immunity) or Th2-type responses (character-
ized by production of IL-4 and IL-5, and associated with humoral immunity) was 
important because it provided a basis for understanding how T cells contribute to 
resistance, or susceptibility to cysticercosis (14). Subsequent studies distinguished 
the role of IL-12 and IL-4 in the development of Th1 and Th2 responses, respec-
tively, but there are other cytokines involved in this process (13). Succintly, it can be 
sustained that immune response to the worm (adult stage of T. solium) is limited to 
Th2-type mechanisms, while the line of defense against the cysticercus is a mixed 
Figure 1. 
Cysticerci or adult parasite and associated host immune cells. Mi, microglia/dendritic cell; Mo, macrophage; 
No, neutrophil; Eos, eosinophil; Th, T helper lymphocyte; Th1, T helper lymphocyte type 1; Th2, T helper 
lymphocyte type 2; BL, B lymphocyte; PC, plasmatic cell.
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Th1-Th2-type immune response, with dominance of Th1-type immune response 
mechanisms involved in limiting parasite growth and expansion (Figure 1).
3. Sources and effects of controversy
Low sensitivity and specificity of IDxNC, as well as variability of results within 
each method and irregular reproducibility between different laboratories, are 
cause of discussion and confusion. More than 50 years of insufficiently planned 
and disaggregated individualistic research using different materials, reagents, 
techniques and conditions of endemial are involved. Policy of publication favor-
ing alleged breakthroughs tells the luminous half of the stories, creating the false 
impression that similar results are to be expected by all. The surging of commercial 
kits and their accompanying propagandistic fanfare has fueled dispute and nur-
tured distrust because of suspected conflicts of interest without much improvement 
in diagnostic capacity. The serious problem caused by all this is that the jingle of 
controversy and confusion has reached medical practice and introduced doubts on 
the significance of serology in medical diagnosis and epidemiological study surveys. 
This has in turn retarded the recognition of T. solium disease as the great threat it is 
to human health and the high costs it incurs to public health in endemic countries. It 
might be of help to clarify the major causes behind the low performance of IDxNC 
as a preliminary step to reach a consensual agreement on the meaning of its results, 
its limitations and the ways for improvement.
Low performance and variability are usually thought to rise from the techni-
cal virtues or pitfalls of the different available immunological tools and reagents 
used. There is some reason for argument here but there is much more than that to 
fully explain the incoherent results and to incorporate in the design of a strategy 
with a chance of worldwide solid success. Rarely is it recognized faulty results 
may rise from over-simplified immunological assumptions about this particular 
host–parasite relationship, incomplete knowledge of the T. solium antigen reper-
toire and/or the immunological complexities derived from the many forms  
T solium has of affecting humans. Because the pleomorphism in T. solium disease 
sets the levels of difficulty for immunological discrimination and is the least 
recognized cause of controversial results, here we shall describe in somewhat 
fastidious detail its many different faces.
The exercise illustrates how hard it is the task of immunotests when put 
to effectively discriminate from the multiple faces of T solium disease the one 
and only of NC. It will also suggest ways of clustering the significant from the 
insignificant discriminations, for medical as distinguished from epidemiological 
purposes, as well as point to what is possible and what impossible. Inevitably, 
some of the major immunological assumptions behind the presence or absence 
of antibodies and/or antigen in an individual must be dealt-with to some extent 
since they interact with the disease polymorphism to increment the difficulties 
of immunodiagnosis for NC. The exercise also explains many of the discrepant 
findings and should clear some of the controversy as well as point to ways of 
improvement.
4. The many faces of T. solium disease
Any human population under consideration may be divided in two sets accord-
ing to their having had come in contact with T. solium (I) or not (0) (Figure 2). 
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The set I includes at least 48 different subsets depending on whether the contact 
occurred a long (l) or short (s) time before sampling; the parasite was rejected (r) 
or it victoriously established in the host (v); the parasite is in the stage of a tape-
worm (t) or as a cysticerci (c); if the cysticerci is located in the nervous system (n) 
or elsewhere (e) or in both (ne); if the cysticerci are few (f) or multiple (m); and if 
they are dead (d) or alive (a) or degenerating (x) (Figure 2).
The projection of positive serology upon the I set involve a number of immuno-
logical assumptions listed in Table 1.
Assuming the minimal, it may be concluded that:
1. Antibodies are to be found only in members of the I set in any of its  
subsets; and
2. Antigens are to be found only in members of the I subsets carrying live  
parasites at the time of sampling.
In consequence:
1. The finding of antibodies in an individual would be indicative of contact but 
would not establish the diagnosis of NC; and
2. The finding of antigen would establish the presence of a parasite in the form of 
cysticerci located either in the brain and/or elsewhere (i.e., skeletal muscle) or 
of an intestinal tapeworm.
If additional assumptions are added, then:
Figure 2. 
Schematic representation of the different possible subsets of the contact and infection of human population 
with Taenia solium.
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3. Antibodies and antigens would be more likely (but not exclusively) to be found 
in all the r subsets of I that combine with m and a (that is, in all cysticercosis 
cases, acquired shortly or long before sampling, with many and live cysticerci 
located in the brain or elsewhere) and in tapeworm carriers. But more likely 
they would be found in the CSF in the neurocysticercosis (n) subsets combin-
ing with m and a, in the SERUM for the e (elsewhere cysticercosis) subsets also 
combining with m and a, and in the feces of t (carriers of live tapeworms). The 
precise magnitude of each likelihood is to be assessed in perhaps each endemic 
situation.
5. Clearing some discrepancy
From the above description of the variety in T. solium disease of humans and 
the usual and rather liberal assumptions about the quality of the immunological 
reactants and the nature of the immune response to this particular parasite many 
of the discrepancies in the performance of different immunotests in different trials 
may be explained. The most important being the variation in the composition of the 
set of control not-NC individuals (i.e., some containing more members of the e or 
t subsets of I would thwart specificity due to many false positive results) and/or in 
the control NC individuals (in which an undue number of the d subset would lower 
sensitivity). Likewise, the control NC individuals are frequently a mixed lot of NC 
patients, differing in time of evolution, number and location of cysticerci, form 
and time of medical and surgical treatment, general health and nutritional status, 
age, gender, race, etcetera, that can possibly affect their immune reactivity [39–46] 
(Figure 3).
The use of domestic and probably differently composed sets of presumed 
control I and 0 individuals and of NC and not-NC individuals accompanying each 
immunotest trial is widespread and thus suspect of being a major cause of incoher-
ent results between trials.
Variation between different trials would also follow from differences in the 
probability distribution of immunologically positive and negative individuals in dif-
ferent situations of endemia (i.e., high and low endemia, urban and rural transmis-
sion) and in the simplification of the forms of disease by way of binomial variables 
(i.e., long or short time of exposure before sampling, single or multiple cysticerci, 
Minimal 1. Antigens used in the immunotest are specific of T. solium and present in all members 
of the species at all stages of development
2. There are no natural antibodies to the parasite.
3. There are no antiidiotipic antibodies simulating antigens.
4. All humans produce antibodies to at least a small and the same subset of the  
T. solium antigens in the immunotest.
Additional 5. Antibodies and antigens tend to:
a. disappear with time after an unsuccessful attempt of the parasite to establish in 
the host,
b. increase with the number of parasites established and
c. concentrate in the compartment where the parasite is located.
Table 1. 
Immunological assumptions involved upon positive serology within the I group (persons who has or had contact 
with Taenia solium).
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dead or alive (not dying) when they are not really so (i.e., individual may be car-
rying 1, 2, ..., n cysticerci) and some are continuous (i.e., time of exposure before 
sampling) and even non-disjunctive (i.e. dead, degenerating and live cysticerci may 
coexist in an individual).
The selection of the T. solium antigens to be used as reactants in the immunotests 
also vary widely among the different immunotests and also within the same immu-
notest applied to different endemic conditions and geographic locations.
6. Immunological assumptions
Of all the immunological assumptions necessary to interpret the results of 
immuno tests in diagnosis of NC, the less tenable are those implying there are no 
cross-reactions with other parasites endemic in the area, that all humans react 
equally to infection and that the set of antigens selected for the immunotest are 
shared by all individual cysticerci and tapeworm in the species (Figure 4).
The question of antigen cross-reactivity is usually dealt-with by selection of the 
set of T. solium antigens most reactive with positive control samples (confirmed NC 
cases) and less reactive with negative control samples (presumably without NC), all 
gathered from donors residing in the endemic areas [47, 48]: a sensible procedure 
in principle but usually lacking in proof of the statistical representation of the 
population affected by the other pathogens and in the certainty of negative control 
samples with respect to clinically silent NC and cysticercosis located elsewhere. 
Failure to control antigen cross-reactivity results in false positive tests. That not all 
humans react equally to infection is an additional source of false negative immu-
notests. Heterogeneous immune response of humans to pathogens is well known 
in a number of infections, possibly all, and although not thoroughly explored in 
T. solium disease it follows from differences in levels of antibodies of control and 
problem samples as well as differences in the published images of WB [47–49]. 
Besides, NC cases donating samples to use as positive controls usually differ in some 
Figure 3. 
Factors involved in neurocysticercosis. The development of neurocysticercosis depends on many factors 
from either the host or the parasite. The factors affecting the immune response of the host are particularly 
important for the immunodiagnosis of NC as they may affect the results between individuals.Differences 
in representativity of the whole of the parasite antigens and in cross-reactivity with other antigens in the 
geographic and endemic background, as well as differences in relative concentrations of reactants and 
conditions of reaction are additional suspect sources of variation.
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or various characteristics of the disease likely to be of immunological consequence 
(i.e., form and duration of treatment, natural history of the disease, site of resi-
dence, age [39], gender [40, 43–45, 50], race [28, 51–54]).
Thus, IDxNC is placed between the wall of false positives and the sword of false 
negatives and forced to negotiate selecting the antigen(s) most frequently found to 
react with control NC samples in order to decrease false positives but conceding some 
false negatives with the consequent loss in both sensitivity and specificity scores.
The antigen repertoire of T. solium is known to be numerous and varied  
[47, 48, 55, 56] but the distribution of the antigens in the members of the species, 
in the different developmental stages of the parasite and in different geographic 
locations is perhaps the most neglected possibly crucial need of information for 
the design of successful immunodiagnosis of T. solium disease.
7. Proposals for improvement
1. T solium disease is too serious a human problem to make of it an arena of 
scientific and technological individualistic rivalry. Cooperation is necessary to 
concert a worldwide effort to design an exacting research plan concordant with 
the complexities of T. solium disease and to develop and test in the short term 
a minimal number of options from which to select the most proficient IDxNC 
possible to be put to immediate production and general use while further re-
search for improvement continues.
2. There is no hope for immunodiagnosis of T. solium disease without clearing 
the problem of antigen cross-reactivity and species representation. Purifica-
tion of antigen(s) or epitopes critically certified to be exclusive of T. solium 
and present in all members of a representative sample of parasite specimens 
of an endemic site is mandatory. Although some likely candidates have been 
Figure 4. 
Failure in immunodiagnosis. Cross-reactivity occurs due to some, but not all, of the secretion and excretion 
antigens of Taenia solium that are shared, not only during the different stages of its biological cycle, but also 
with some other endemic parasites (eg: Taenia saginata).
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proposed [55, 57, 58] they are lacking in satisfactorily meeting with either one 
or both of these conditions. A way of avoiding the high costs and demand-
ing technical skills involved in the purification of natural antigens is the use 
of those present in phage display peptide libraries [59–61]. Antigens present 
in only T. solium but not in all specimens of the species would constitute the 
candidate antigen preparation (CAP).
3. It is also necessary to study and characterize the presumed wide spectrum 
of humans’ antibody production in T solium disease in order to calibrate the 
candidate antigen preparation that would include all infected individuals. WBs 
using CAP in reaction with representative samples of all subsets of I, if pos-
sible, or of n and e at least, would provide the images necessary to construct all 
immunological profiles of the infected individuals. Computer assisted image 
analysis of WB and cluster analysis could address this problem. The set of CAP 
that reacts with all or most infected individuals would constitute the definitive 
antigen preparation (DAP).
4. Rather than attempting to develop ways to distinguish each of the different 
subsets of T. solium disease, efforts in immunodiagnosis could focus in improv-
ing diagnosis of NC (to include all subsets with n and ne to the exclusion of 
all other subsets of I as t and e), whilst for prevalence of T. solium disease, in 
whatever its form, it should only clearly distinguish members of the I set from 
those of 0.
Three are the classes of T. solium disease that matter the most and perhaps re-
quire different strategies: the contact case (members of the I set), the NC case 
(all n and ne subsets) and the tapeworm carrier (t subset). For this purpose, it 
is indispensable to construct representative and certified negative and positive 
control panels of the samples CSF, serum and feces from each geographic area 
upon their reaction with DAP. Certification of the members of the e subset and 
0 set is complicated by its need of whole-body scans in search of cysticerci lo-
cated elsewhere of CNS. Additional negative control samples from a culturally 
and historically certified community or geographic area to be rid of T. solium 
disease and low in infectious disease in general would be useful to estimate 
blank readings of immunotesting with DAP.
5. Once the problem of antigen specificity and representation is solved there 
should be no major problem to IDxNC in the CSF of a symptomatic neurologi-
cal patient nor of an intestinal tapeworm in the feces, preferably by antigen 
detection (this, to distinguish cysticercosis located elsewhere and live from 
dead cysticerci in the CNS because antibodies could persist after death of the 
parasite for unknown periods of time).
6. But there would remain serious problems to tackle for serology, the most 
accessible sample useful for detection of early nonsymptomatic NC cases in 
the general population and for epidemiological studies of T. solium disease 
prevalence. The major problem for serology in unambiguously detecting 
asymptomatic NC cases is the potential location elsewhere of the parasite (all 
e subsets and the t subset) that produces false positive results, and the low 
reactivity of patients with few or calcified cysticerci (f and d subsets) that 
produces false negative results. Adding to positive serology a marker of CNS 
damage [62, 63] as a sign of CNS involvement could help in discriminating 
NC from other forms of T. solium disease.
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